The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
776
October 7, 1988
View Complete Issue         Table of Contents 2019 
Extracorporeal Photochemotherapy for Cutaneous T-cell Lymphoma
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Extracorporeal Photochemotherapy for Cutaneous T-cell Lymphoma
October 7, 1988 (Issue: 776)
Photopheresis is a new technique recently approved by the US Food and Drug Administration for treatment of cutaneous T-cell lymphoma. It combines oral administration of a photoactivatable cytotoxic drug with leukapheresis and extracorporeal...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Extracorporeal Photochemotherapy for Cutaneous T-cell Lymphoma
Article code: 776c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.